Creative Medical Technology Holdings Inc CELZ

NAS: CELZ | ISIN: US22529Y3099   1/05/2025
1,990 USD (-3,86%)
(-3,86%)   1/05/2025
Grafiek Creative Medical Technology Holdings Inc Grafiek Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc in het nieuws

10 oktober 2023 · Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain · Persbericht

19 september 2023 · Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain · Persbericht

28 juni 2023 · Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements · Persbericht

12 juni 2023 · Creative Medical Technology Announces $2 Million Share Repurchase Program · Persbericht

12 juni 2023 · Creative Medical Technology Holdings Provides Corporate Update · Persbericht

9 juni 2023 · Creative Medical Technology Holdings Announces Reverse Stock Split · Persbericht

31 mei 2023 · Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform · Persbericht

22 mei 2023 · Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development · Persbericht

18 mei 2023 · Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line · Persbericht

12 april 2023 · Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study · Persbericht

Profiel Creative Medical Technology Holdings Inc

Diversen

Mijn selecties